LMAT241115P90000
- 0.75
- -5.13-87.24%
LeMaitre Vascular Newsroom
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
LeMaitre Vascular Analyst Ratings
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $93 to $100
Cantor Fitzgerald Initiates LeMaitre Vascular(LMAT.US) With Hold Rating, Announces Target Price $96
LeMaitre Vascular Is Maintained at Outperform by Barrington Research
LeMaitre Vascular Analyst Ratings
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $92
Lemaitre Vascular's Growth Prospects Bolstered by Pricing Power and Strategic Expansion: A Buy Rating Review
Lake Street Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $105
Lemaitre Vascular (LMAT) Gets a Buy From Lake Street
LeMaitre Vascular Analyst Ratings
JMP Securities Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $100
Lemaitre Vascular's Strong Financial Performance and Growth Potential Warrant a Buy Rating
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $92 to $105
LeMaitre Vascular Analyst Ratings
Buy Rating Affirmed for Lemaitre Vascular Amid Strong Fiscal Performance and Growth Prospects
Roth MKM Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $100
Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $95
KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
Lemaitre Vascular (LMAT) Receives a Hold From KeyBanc